Interstitial lung diseases in connective tissue diseases: patient’s journey from diagnosis and new treatment strategies to transplantation
Symposium Chairs: F. Meloni (Pavia (PV), Italy), T. Welte (Hannover, Germany)
Aims: to update attendees about the management of interstitial lung diseases (ILDs) associated with connective tissue diseases (CTD-ILDs), which has recently evolved with the increasing numbers of prescription for antifibrotics in addition to immunosuppressive drugs; to provide an update about diagnostic practice and assess the adjunctive value of a multidisciplinary approach to diagnosis; to describe therapeutic strategies and analyse the timing and contraindications of lung transplant referral as well as post-transplant management and outcomes; to discuss novel insights into the diagnostic procedure and the implication of genetics.